Trial updateGlaucoma
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Recruiting. Phase 2. Registered enrolment: 110. Glaukos Corporation
Why it matters
Track this study through NCT07075718. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 2
- Registered enrolment
- 110
- Results posted
- No
- Sponsor
- Glaukos Corporation
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.